2024-11-12 - Analysis Report
## AbbVie Inc. (ABBV) Stock Analysis Report

**Company Overview:** AbbVie Inc. is a global biopharmaceutical company that develops, manufactures, and markets a broad range of medicines, including treatments for autoimmune diseases, cancer, and other chronic illnesses.

**1. Performance Analysis**

| Metric | Value |
|---|---|
| **Ticker:** | ABBV |
| **Cumulative Return:** | 158.56% |
| **S&P 500 (VOO) Cumulative Return:** | 142.82% |
| **Performance Difference:** | 15.74% |
| **Relative Performance (Rank):** | 57.3% | 

**Alpha and Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Market Cap (B) |
|------------|------|------|-------|------|---------------|
| 2015-2017  | 46.8% | 30.2% | 16.6% | 1.0 | 170.90 |
| 2016-2018  | 60.0% | 34.1% | 35.3% | 1.0 | 162.91 |
| 2017-2019  | 41.9% | 43.6% | -1.2% | 1.0 | 156.46 |
| 2018-2020  | 8.9% | 43.6% | -30.2% | 0.8 | 189.35 |
| 2019-2021  | 51.7% | 33.7% | -38.1% | 0.7 | 239.27 |
| 2020-2022  | 80.5% | 33.7% | 62.7% | 0.6 | 285.59 |
| 2021-2023  | 47.0% | 22.4% | 18.2% | 0.4 | 273.85 |
| 2022-2024  | 47.3% | 22.4% | 22.1% | 0.3 | 354.33 |

**Analysis:** AbbVie has outperformed the S&P 500 in terms of cumulative return. Its relative performance is strong, currently ranking at the 57.3% percentile based on historical data. Alpha and Beta values indicate the stock has historically outperformed the market (positive Alpha) and has been less volatile than the market (Beta less than 1).

**2. Recent Price Action**

| Metric | Value |
|---|---|
| **Closing Price:** | 199.5 |
| **Last Market:** | 175.1 |
| **5-Day Moving Average:** | 200.67 |
| **20-Day Moving Average:** | 194.37 |
| **60-Day Moving Average:** | 194.83 |

**Analysis:**  The stock price is currently above its 5-day, 20-day, and 60-day moving averages. This indicates potential upward momentum. However, the recent market price (175.1) is significantly lower than the closing price (199.5), indicating a possible recent drop.

**3. Technical Indicators**

| Indicator | Value | Analysis |
|---|---|---|
| **RSI:** | 71.64 |  The RSI is above 70, indicating the stock is in overbought territory. This could suggest a potential correction in the near term. |
| **PPO:** | 0.45 | A positive PPO value indicates that the price momentum is positive. |
| **Delta_Previous_Relative_Divergence:** | -0.77 |  A negative value indicates a recent decrease in the relative performance of the stock. |
| **Expected Return:** | 2.95% |  This indicates a positive long-term expected return for ABBV, suggesting it could outperform the S&P 500 in the next two years. |

**4. Recent Earnings and Outlook**

| Date | EPS | Expected EPS | Analysis |
|---|---|---|---|
| 2024-10-30 | 3 | 2.92 | The most recent earnings report slightly exceeded expectations, demonstrating consistent performance. |
| 2024-07-25 | 2.65 | 2.57 |  Slightly exceeded expectations, consistent performance. |
| 2024-04-26 | 2.31 | 2.26 |  Slightly exceeded expectations, consistent performance. |
| 2024-02-02 | 2.79 | 2.76 |  Slightly exceeded expectations, consistent performance. |
| 2023-10-27 | 2.95 | 2.86 |  Slightly exceeded expectations, consistent performance. |

**Analysis:** ABBV has consistently exceeded earnings expectations over the past year. This indicates strong fundamental performance and positive market outlook. 

**5. Financial Information**

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin | Analysis |
|---|---|---|---|
| 2024-09-30 | $14.46B | 70.87% |  Profit margin is stable and high, indicating strong profitability. |
| 2024-06-30 | $14.46B | 70.94% | Profit margin is stable and high, indicating strong profitability. |
| 2024-03-31 | $12.31B | 66.74% | Profit margin is still high, but slightly lower than previous quarters, potentially influenced by economic factors. |
| 2023-12-31 | $14.30B | 60.11% | Profit margin is still high, but lower than previous quarters, potentially influenced by economic factors. |
| 2023-09-30 | $13.93B | 53.44% | Profit margin is high but has been consistently decreasing for the past few quarters. |

**Capital and Profitability**

| Quarter | Equity | ROE | Analysis |
|---|---|---|---|
| 2024-09-30 | $6.03B | 25.88% |  ROE indicates strong profitability and efficient utilization of capital. |
| 2024-06-30 | $6.78B | 20.21% | ROE remains high, indicating consistent profitability. |
| 2024-03-31 | $8.01B | 17.10% |  ROE continues to decline, suggesting potential future challenges. |
| 2023-12-31 | $10.36B | 7.93% |  ROE is lower than previous quarters, potentially influenced by economic factors. |
| 2023-09-30 | $12.09B | 14.70% |  ROE is lower than previous quarters, potentially influenced by economic factors. |

**Analysis:** ABBV has consistently shown strong profitability, with high profit margins and return on equity. However, there is a trend of decreasing ROE and profit margins in recent quarters, potentially indicating future challenges or economic pressures. 

**6. News and Recent Issues**

* **Earnings News:** Check the company's website, press releases, and financial news websites like Shacknews for the latest earnings reports and analyst commentary. 
* **Market Outlook:**  Use financial news and analysis platforms like FINBOLD to get the latest market outlook on ABBV. Analyze analyst opinions and performance highlights.

**7.  Overall Analysis**

* ABBV has a strong track record of outperforming the market and has a solid financial foundation.  
* Recent earnings have been consistently positive, indicating strong fundamental performance.
* However, the stock is currently in overbought territory, and recent price action suggests a potential correction. 
* Keep an eye on financial data for trends in ROE and profit margins, as they may indicate future challenges.

**8.  Recommendation**

ABBV has a strong long-term growth potential based on its fundamentals and positive expected return. However, the stock is currently in overbought territory, indicating a potential short-term correction. Consider a long-term investment strategy, allowing for potential volatility while taking advantage of its growth potential. 
